Kayla Jackson
Nurse Practitioner · Alexander City, ALNPI 1811545718
Payments from drug & device makers
Across 187 payments — averaging $12.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Exact Sciences$182
- Bayer$136
- Collegium Pharmaceutical, Inc.$131
- AstraZeneca$119
- AbbVie$110
- plus $586 from 13 others
What the payments were for
- Food & beverage$2,32997%
- Education$663%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 112 | $1,131 |
| Exact Sciences | 9 | $182 |
| Bayer | 5 | $136 |
| Collegium Pharmaceutical, Inc. | 20 | $131 |
| AstraZeneca | 6 | $119 |
| AbbVie | 4 | $110 |
| Nevro Corp. | 5 | $92 |
| Biodelivery Sciences International, Inc. | 5 | $91 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $89 |
| Astellas Pharma US Inc | 1 | $66 |
| Novo Nordisk | 3 | $58 |
| Amgen | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| GSK | 1 | $14 |
| Forte Bio-pharma LLC | 1 | $5 |
How this compares
$2,395 in reported general payments places this provider in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $41,253 |
| FarxigaDapagliflozin Propanediol | 31 | $37,319 |
| JanuviaSitagliptin Phosphate | 27 | $26,495 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $19,954 |
| LinzessLinaclotide | 15 | $19,945 |
| VraylarCariprazine Hcl | 11 | $16,317 |
| Lagevrio (Eua)Molnupiravir | 14 | $13,272 |
| EliquisApixaban | 14 | $12,372 |
| JardianceEmpagliflozin | 18 | $11,666 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $7,532 |
| TradjentaLinagliptin | 11 | $6,762 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 17 | $5,330 |
| Atorvastatin Calcium | 157 | $2,183 |
| Humalog Kwikpen U-100Insulin Lispro | 14 | $2,009 |
| Omeprazole | 87 | $1,929 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $58 | $41,25338 claims |
| AbbVieLinzess, Vraylar, Synthroid | $110 | $37,32345 claims |
| AstraZenecaFarxiga | $119 | $37,31931 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $14 | $27,48641 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $19 | $1,57614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Alexander City
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.